Resources

Publications

10/08/2023
- Oncology
An analysis of 13 independently performed assays to measure homologous recombination deficiency using 90 freshly extracted high grade serous ovarian tumors: findings from the friends of cancer research hrd harmonization project
AACR Ovarian Cancer Special Session 2023
10/08/2023
- Oncology
Characterizing the Genomic and Immune Landscape of Serous Borderline Tumors And Low-Grade Serous Ovarian Cancer
AACR Ovarian Cancer Special Session 2023
10/05/2023
- Oncology
Circulating Tumor DNA for Early Risk Stratification of Oligometastatic Lung Cancer
ASTRO 2023
10/04/2023
- Oncology
Pre-radiotherapy ctDNA Liquid Biopsy for Risk Stratification of Oligometastatic Non-small Cell Lung Cancer
npj Precision Oncology
10/02/2023
- Oncology
Uncovering Molecular Differences in Pancreatic Ductal Adenocarcinoma Tissues From Black and White Patients in the US
AACR Cancer Health Disparities 2023
09/30/2023
- Oncology
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study Program
Clinical Therapeutics
09/15/2023
- Oncology
Assessing the Utility of Molecular Diagnostic Classification for Cancers of Unknown Primary
Cancer Medicine
09/01/2023
- Oncology
Utility of RNA Expression to Determine the Tissue of Origin of Malignancies with an Inconclusive Histopathology
Case Reports in Oncology
08/23/2023
- Oncology
Pitfalls in Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
The Journal of Pathology
08/17/2023
- Oncology
Neratinib + Fulvestrant + Trastuzumab for HR-Positive, HER2-Negative, HER2-Mutant Metastatic Breast Cancer: Outcomes and Biomarker Analysis From the SUMMIT Trial
Annals of Oncology

28 29 30